Company intelligence / Profile preview

Pregnolia

Ownership: Private
Employees: ~15
Development stage: Other

Overview

The Pregnolia System enables healthcare providers to measure cervical stiffness as an indicator of preterm birth risk. Ongoing clinical studies are building a comprehensive database to validate its predictive value. The device has CE certification and quality management per EN ISO 13485. FDA approval strategy for US market underway; early commercial use in Switzerland and Germany.

Therapeutic areas: Women's Health
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Collaborations with European academic hospitals/universities for clinical studies (ETH Zürich, University Hospital Zürich)

Beyond the preview

Go deeper on Pregnolia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pregnolia.

Explore the full profile